Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Thumbnail

Artificial heart provides option for some patients

Only a handful of patients receive artificial hearts each year, but The Verge reports the device's manufacturers are hoping they can one day replace real hearts. Artificial hearts are now used as life support for people waiting for transplants.

Thumbnail

Early invasive treatment strategy after acute coronary syndrome appears to be effective

Patients with acute coronary syndromes who underwent an early invasive strategy had a lower risk of cardiac death and hospitalization for MI compared with those who received a conservative approach, according to a retrospective cohort study.

Thumbnail

IABP therapy is associated with higher mortality in patients undergoing PCI

An observational study involving Japanese patients undergoing PCI found the use of intra-aortic balloon pump (IABP) therapy was associated with a significantly higher risk of in-hospital mortality.

Thumbnail

[ARTICLE] Building a Protected PCI Program: The Programmatic Approach

Offered in cooperation with Abiomed

The University of Washington Medical Center in Seattle, already a major national referral center, has recently undergone a significant culture shift. The change began when Robb MacLellan, MD, joined as chief of cardiology of UW Medicine Regional Heart Center in 2011.

Thumbnail

Technology Refresh: Integrating Cath Lab to CVIT

Sponsored by GE Healthcare

Growth seeded the need for a dedicated PCI program at Saratoga Hospital that went live in January along with a complete technology overhaul: cath lab, hemodynamic monitoring, echocardiography and a fully integrated cardiovascular information system. The PCI program, close to 100 interventions later, is now considered a jewel of the county and a model for other facilities considering a technology refresh.

Thumbnail

Robotics in the Cath Lab: Balancing Physician Safety with Cost Concerns

Once just a feature of science fiction, robotics is now an integral part of the current healthcare landscape. With the advent of robotic-assisted percutaneous coronary intervention (PCI), interventional cardiology may be poised to experience a tectonic shift.

Thumbnail

Quest voluntarily recalls some of its MPS delivery sets for use during open heart surgery

Quest Medical voluntarily recalled certain lots of its Myocardial Protection System (MPS) delivery sets on Oct. 28 after finding the products had a possible seal failure that could lead to blood loss in patients.

ACC, AHA, SCAI release updated guidelines on multivessel PCI and thrombus aspiration

Major medical societies released updated guidelines on Oct. 21 regarding multivessel PCI and thrombus aspiration in patients with STEMI undergoing primary PCI.

Displaying 1473 - 1480 of 2707

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.